gip glp 1 agonist LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor for glycemic control and weight loss: From discovery to clinical proof of concept Possible mechanisms of action of

Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia

Slow release (also known as controlled release or modified release) formulations can often appear to make input similar to a zero-order input process

Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches

Administration of spironolactone, a selective MR antagonist, counteracted stress-induced mGlu2 suppression and the related development of depressive-like behavior, implicating rapid action of glucocorticoids via a receptor that is known to modulate glutamate release [20]

You can also spit it out, if you prefer

J., Trappetti, C